Phase 3 Clinical Trial Evaluating Continuous Subcutaneous Carbidopa/Levodopa (ND0612) Initiated In The United States For Parkinson's Disease

[Farooqji]

finance.yahoo.com/news/phas...

[aspergerian]

ND0612 update:

Phase 3 Trial of Investigational Parkinson Treatment ND0612 Initiated. Subcutaneous levodopa.

neurologylive.com/clinical-...

[Juliegrace in reply to aspergerian]

Thank you for posting this. I've been following Neuroderm for several years but had not seen this.